ArticlePloS one2025
Wealth creation and disease burden: Evidence from Nigeria based on a Bayesian-VAR approach.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Does wealth creation reduce disease burden for developing countries? In this paper a Bayesian-VAR (B-VAR) model is built to investigate the causal relationships between disease burden, wealth creation, life expectancy at birth and population growth over the period from 2006 to 2018 in Nigeria, a developing country with significant disease burden. Specifically, the use of the impulse response functions and the forecast variance decomposition functions reveal that wealth creation has the greatest impact on disease burden in Nigeria. Our results are consistent with different measurements of wealth creation, including trade in services, personal remittance received, and ease of doing business. We have also found a pronounced response of disease burden to life expectancy at birth and to population growth. Our results suggest that, in Nigeria, policies targeted at wealth creation, with a proper wealth redistribution, are strongly recommended to reduce disease burden and increase life expectancy at birth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.